Journal profile · Medicine-Medicine (miscellaneous)
Nature Biomedical Engineering
ISSN 2157-846X · Springer Nature · United States · 12 issues per year · Founded 2017
Nature Biomedical Engineering: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 25.8; hybrid open access; APC about USD 12,690; median 438 days to acceptance (63 articles, last 24 months); 238 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Nature Biomedical Engineering is published by Springer Nature and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are CRISPR and Genetic Engineering, CAR-T cell therapy research and 3D Printing in Biomedical Research, together about 21.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Straddling the life sciences, the physical sciences and engineering, Nature Biomedical Engineering aims to bring together the most important advances from the broad discipline of biomedical engineering, enhancing their visibility through opinion and news articles, and providing overviews of the state of the art in each field. The journal's scope includes the design, applicability, optimization, validation and deployment of experimental and computational systems and methods that facilitate the understanding of human disease, or that may lead to improvements in human health or healthcare. For more information, please see Aims & Scope.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (miscellaneous)
Editorial board by country: 1 in mainland China (about 8%); most named United States 5, United Kingdom 2, Germany 2, Mainland China 1, Italy 1 (12 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology8.1%
- CAR-T cell therapy researchMedicine7.1%
- 3D Printing in Biomedical ResearchEngineering6.7%
- Neuroscience and Neural EngineeringNeuroscience6.4%
- Immunotherapy and Immune ResponsesImmunology and Microbiology5.6%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5.5%
- Nanoplatforms for cancer theranosticsEngineering5.1%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 25.8LetPub ·
- Impact factor (publisher) 2025
- 26.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 32.6Publisher website ·
- CiteScore 2026-06
- 46.6LetPub ·
- SJR 2026-06
- 9LetPub ·
- SNIP 2026-06
- 4.92LetPub ·
- h-index
- 9LetPub ·
- h-index
- 201OpenAlex ·
- i10-index
- 997OpenAlex ·
- 2-year mean citedness
- 14.68OpenAlex ·
- Self-citation rate
- 0.8%LetPub ·
- Share of gold OA articles
- 33.59%LetPub ·
Volume
- Articles per year
- 175LetPub ·
- Downloads per year (publisher) 2025
- 3,899,030Publisher website ·
Articles by year OpenAlex count · 1,780 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 222 | 97 | 577 |
| 2025 | 238 | 128 | 3,418 |
| 2024 | 159 | 79 | 5,095 |
| 2023 | 178 | 97 | 10,178 |
| 2022 | 169 | 102 | 16,592 |
| 2021 | 159 | 99 | 23,737 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
438 daysMedian, submission to acceptance · P25–P75 321 days – 561 days
- Acceptance to online
- median 45 days (63 articles)
- Submission to online
- median 481 days
- Sample
- 63 articles with submission and acceptance dates (533 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 12,690 / EUR 10,690 / GBP 9,190 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAI use, Peer review, Preprints
- AI use Defining attributes of effective binders for AI-assisted CAR design
Generative artificial intelligence (AI) has revolutionized protein engineering and has enabled de novo design of protein binders against dozens of target antigens. Our study combines AI-assisted binder design, binder integration into chimaeric antigen receptor (CAR) constructs and scalable in vitro and in vivo cell models to infer amino acid sequences and protein structures of designed binders tha…
Source ↗Publisher website ·- Peer review 3 – Editorial Process, Peer Review, Appeals & Transfers
Editorial policies Model summary
Once you have submitted your manuscript, it goes through our editorial process. If your manuscript is sent out for peer review, you will receive an email asking you to read and sign our Editorial Policies. To appeal against a decision, or transfer your submission to another journal – Appeals and Transfers. ____________________________________________________________________________________________…
Source ↗Publisher website ·- Preprints
Preprint policy and In Review Model summary
Our preprint policy – Preprint policy and In Review
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- United States
- Language
- English
- Frequency
- 12 issues per year
- Founded
- 2017
- ISSN
- 2157-846X
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Nature Biomedical Engineering
What CAS zone is Nature Biomedical Engineering in?
In the 2025 upgraded edition of the CAS Journal Ranking, Nature Biomedical Engineering is in Zone 1 of Medicine, and in Zone 1 of the minor category Engineering, Biomedical; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Nature Biomedical Engineering?
The latest impact factor listed by LetPub is 25.8; CiteScore 46.6, h-index 201.
How long does peer review take at Nature Biomedical Engineering?
Based on the dates recorded on 63 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 438 days (interquartile range 321–561 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Nature Biomedical Engineering based?
Of the 12 board members whose country the journal's board page names, 1 (about 8%) are in mainland China; the countries named most often are United States (5), United Kingdom (2) and Germany (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Nature Biomedical Engineering?
According to LetPub and DOAJ records, Nature Biomedical Engineering is indexed in SCIE and Scopus. The journal's website also lists Web of Science; that list has not been checked against each database.
Is Nature Biomedical Engineering open access, and what is the APC?
Nature Biomedical Engineering is a hybrid journal. For open-access publication: APC about USD 12,690.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .